Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/07 → 6/30/08 |
A Phase 2 Study of LY573636 Administered as an Intravenous Infusion on Day 1 of a 21-Day Cycle as Second-Line Treatment in Patients with Unresectable or Metastatic Melanoma
- Rinehart, John (PI)